• Citer

Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis.

par Bidard, François-Clément;Michiels, Stefan ;Riethdorf, Sabine;Mueller, Volkmar;Esserman, Laura J;Lucci, Anthony;Naume, Bjorn;Horiguchi, Jun;Gisbert-Criado, Rafael;Sleijfer, Stefan;Toi, Masakazu;Garcia-Saenz, Jose A;Hartkopf, Andreas;Generali, Daniele;Rothé, Françoise ;Smerage, Jeffrey;Muinelo-Romay, Laura;Stebbing, Justin;Viens, Patrice;Magbanua, Mark Jesus MJM;Hall, Carolyn S;Engebraaten, Olav;Takata, Daisuke;Vidal-Martínez, José;Onstenk, Wendy;Fujisawa, Noriyoshi;Diaz-Rubio, Eduardo;Tarantino, Franca;Cappelletti, M L;Ignatiadis, Michail ;Proudhon, Charlotte;Wolf, Denise M;Bauldry, Jessica JB;Borgen, E;Nagaoka, Rin;Carañana, Vicente;Kraan, Jaco;Maestro, Marisa;Brucker, Sara Yvonne;Weber, Karsten;Reyal, Fabien;Amara, Dominic;Karhade, Mandar MG;Mathiesen, Randi RR;Tokiniwa, Hideaki;Llombart-Cussac, Antonio;Meddis, Alessandra;Blanche, Paul;d'Hollander, Koenraad;Cottu, Paul;Park, John W;Loibl, Sibylle;Latouche, Aurelien;Pierga, Jean-Yves;Pantel, Klaus
Référence Journal of the National Cancer Institute, 110, 6, page (560-567)
Publication Publié, 2018-06

Article révisé par les pairs

• Détails
• Contenu

Résumé :

We conducted a meta-analysis in nonmetastatic breast cancer patients treated by neoadjuvant chemotherapy (NCT) to assess the clinical validity of circulating tumor cell (CTC) detection as a prognostic marker.